≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Palindromic rheumatism

DOID EFO Endpoint Browser PheWeb

M13_PALINDROMIC

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M12.3
  • Hospital discharge: ICD-8 — 71220
  • Cause of death: ICD-10 — M12.3
  • Cause of death: ICD-8 — 71220

2 out of 7 registries used, show all original rules.

400

4. Check minimum number of events

None

400

5. Include endpoints

None

400

6. Filter based on genotype QC (FinnGen only)

396

Control definitions (FinnGen only)

Control exclude
M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M12
Name in latin
Rheumatismus palindromicus

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1936 1191 735
Only index persons 1767 1120 647
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.02
Only index persons 0.04 0.04 0.02
Median age at first event (years)
Whole population 52.21 51.50 53.40
Only index persons 51.77 51.02 53.08

-FinnGen-

Key figures

All Female Male
Number of individuals 396 255 141
Unadjusted period prevalence (%) 0.08 0.09 0.06
Median age at first event (years) 52.59 51.12 55.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
400
Matched controls
4000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P01BA02
ATC
hydroxychloroquine; oral
503.8
307.7
321
32
M12.3
ICD-10 Finland
Palindromic rheumatism
+∞
307.7
366
*
L04AX03
ATC
methotrexate; systemic
84.4
307.7
218
56
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
203.6
307.7
186
17
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
109.9
307.7
271
75
A07EC01
ATC
sulfasalazine; oral, rectal
59.0
282.0
169
49
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
85.1
275.1
150
28
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3731.4
217.4
190
*
M13.9
ICD-10 Finland
Arthritis, unspecified
44.7
163.8
101
30
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
14.0
105.7
111
107
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
21.4
105.3
84
49
L88
ICPC
Rheumatoid/seropositive arthritis
177.2
103.9
105
8
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
416.2
98.7
95
*
H02AB06
ATC
prednisolone; systemic
10.1
93.7
323
1175
M25.5
ICD-10 Finland
Pain in joint
7.2
86.9
200
485
M17.1
ICD-10 Finland
Other primary gonarthrosis
14.9
84.0
81
67
L04AA13
ATC
[U] leflunomide
447.0
76.5
74
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
73.2
68
*
L01BA01
ATC
methotrexate; systemic
177.9
71.6
73
5
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
169.1
68.4
70
5
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
770.7
68.1
65
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
64.3
60
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
714.5
63.7
61
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
175.9
58.7
60
*
L04AB01
ATC
etanercept; parenteral
+∞
43.5
41
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
10.2
41.2
49
54
M01CB01
ATC
sodium aurothiomalate; parenteral
+∞
40.3
38
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
40.3
38
*
H02AB07
ATC
prednisone; oral
4.9
36.4
95
238
71220
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Palindromic rheumatism
+∞
33.8
32
*
M01AH01
ATC
celecoxib; oral
4.4
33.1
101
285
L20
ICPC
Joint symptom/complaint NOS
9.9
32.7
39
43
M79.0
ICD-10 Finland
Rheumatism, unspecified
10.1
32.3
38
41
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
10.9
32.3
36
36
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.4
31.1
190
849
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
8.0
29.0
41
56
M01AH05
ATC
etoricoxib; oral
3.4
28.6
277
1598
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
51.2
27.9
33
7
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.5
26.4
55
112
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
+∞
26.3
25
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
100.1
26.0
28
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
10.7
25.9
29
29
ZX140
NOMESCO Finland
Intra articular
+∞
25.3
24
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
10.7
25.0
28
28
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
24.6
24.3
34
15
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
+∞
24.2
23
*
N02AX02
ATC
tramadol; systemic, rectal
2.8
23.0
189
959
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
22.9
214
1161
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.8
22.4
190
977
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
22.1
21
*
L04AB04
ATC
adalimumab; parenteral
30.0
21.2
28
10
M10.9
ICD-10 Finland
Gout, unspecified
7.6
21.1
31
44
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
+∞
21.0
20
*
TNG10
NOMESCO Finland
Puncture of knee
221.0
20.8
21
*
M01AE02
ATC
naproxen; oral, rectal
2.7
20.1
254
1567
A02BC02
ATC
pantoprazole; systemic
2.9
20.0
298
1996
M01CB03
ATC
auranofin; oral
+∞
20.0
19
*
NF1AA
NOMESCO Finland
Hip X-ray examination
5.7
19.8
39
75
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.7
19.6
48
112
M20.1
ICD-10 Finland
Hallux valgus (acquired)
15.9
19.3
31
21
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
6.8
19.1
31
49
M35.3
ICD-10 Finland
Polymyalgia rheumatica
6.5
17.9
30
49
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
17.8
17
*
M01AB55
ATC
diclofenac, combinations; oral
4.9
17.0
39
86
M01AH02
ATC
rofecoxib; oral
3.6
16.8
62
195
L04AK01
ATC
leflunomide; oral
+∞
16.8
16
*
L04AX01
ATC
azathioprine; systemic
5.9
16.8
31
56
M13.0
ICD-10 Finland
Polyarthritis, unspecified
94.1
16.7
18
*
M79.6
ICD-10 Finland
Pain in limb
2.4
16.6
174
958
H02AB04
ATC
methylprednisolone; systemic
3.2
16.4
76
276
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
49.7
16.2
19
*
N03AX16
ATC
[U] pregabalin
2.8
16.0
98
415
L15
ICPC
Knee symptom/complaint
2.8
15.0
87
357
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
19.3
14.9
22
12
M06
ICD-10 Finland
Other rheumatoid arthritis
+∞
14.7
14
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.6
14.6
36
84
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
155.4
14.6
15
*
M01AC06
ATC
meloxicam; systemic, rectal
2.3
14.5
154
843
WX320
NOMESCO Finland
Spinalanesthesy
2.8
14.1
85
356
L04AB06
ATC
golimumab; parenteral
77.9
13.7
15
*
J01DB01
ATC
cefalexin; oral
2.8
13.6
337
2612
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
144.7
13.5
14
*
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.6
13.4
26
49
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
13.4
55
185
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
41.6
13.2
16
*
L28
ICPC
Limited function/disability (L)
2.8
13.1
73
292
M13.8
ICD-10 Finland
Other specified arthritis
51.8
12.9
15
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
12.6
12
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
+∞
12.6
12
*
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
134.0
12.5
13
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
12.4
163
960
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.9
12.4
38
105
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
12.3
53
183
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
11.6
12.2
22
20
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
18.8
12.2
18
10
SPAT1202
SPAT
Intra-articular injection
10.5
12.2
23
23
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
27.7
12.1
16
6
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
14.0
12.1
20
15
M01AX17
ATC
nimesulide; oral
2.4
11.9
103
510
M79.7
ICD-10 Finland
Fibromyalgia
5.8
11.8
22
40
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
11.7
127
690
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.6
11.7
41
124
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
11.6
11.7
21
19
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
+∞
11.5
11
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
11.5
11
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
+∞
11.5
11
*
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
+∞
11.5
11
*
NG1DA
NOMESCO Finland
X-ray of knees
123.4
11.5
12
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
11.5
97
474
M04AA01
ATC
allopurinol; systemic
3.1
11.3
50
175
M01AX05
ATC
glucosamine; oral
2.9
11.3
59
227
M35.7
ICD-10 Finland
Hypermobility syndrome
20.8
11.2
16
8
R06AE07
ATC
cetirizine; oral
2.1
11.2
182
1153
SPAT1059
SPAT
Spirometry at the office
4.2
11.2
30
75
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
10.9
87
413
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
16.1
10.9
17
11
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
28.9
10.8
14
5
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
22.2
10.8
15
7
M54.5
ICD-10 Finland
Low back pain
2.1
10.7
141
822
S18
ICPC
Laceration/cut
2.0
10.7
178
1131
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
61.7
10.7
12
*
SPAT1249
SPAT
Treatment-related counselling outside office
2.0
10.7
168
1047
B01AF01
ATC
rivaroxaban; oral
3.1
10.5
45
155
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
+∞
10.5
10
*
A46
ICD-10 Finland
Erysipelas
2.7
10.4
60
244
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
19.4
10.3
15
8
L11
ICPC
Wrist symptom/complaint
3.0
10.1
46
164
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
10.1
156
962
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
41.2
10.0
12
*
SPAT1211
SPAT
Application of soft bandage
3.3
10.0
40
132
L04AA01
ATC
[U] ciclosporin
17.2
9.9
15
9
SPAT1153
SPAT
Removal of sutures
2.1
9.7
121
688
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
9.6
64
279
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
102.4
9.5
10
*
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
+∞
9.4
9
*
M17.5
ICD-10 Finland
Other secondary gonarthrosis
+∞
9.4
9
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.7
9.4
56
231
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
9.4
81
397
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
9.3
95
498
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
9.3
86
433
ACC51
NOMESCO Finland
Release of median nerve
3.5
9.2
32
96
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.6
9.2
60
258
R03BA01
ATC
beclometasone; inhalant
2.5
9.1
63
279
M01AB05
ATC
diclofenac; systemic, rectal
1.9
9.1
257
1921
A02BC05
ATC
esomeprazole; systemic
1.9
9.0
164
1059
L17
ICPC
Foot/toe symptom/complaint
2.1
9.0
109
611
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
8.9
144
894
N02AA05
ATC
oxycodone; systemic
2.4
8.9
70
329
Z01.2
ICD-10 Finland
Dental examination
1.9
8.8
170
1118
M02AA10
ATC
ketoprofen; topical
2.4
8.7
67
311
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
51.1
8.7
10
*
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
51.1
8.7
10
*
A02BA02
ATC
ranitidine; systemic
2.2
8.7
83
423
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
4.7
8.7
20
44
L90
ICPC
Osteoarthrosis of knee
4.9
8.7
19
40
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.4
8.6
32
101
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
8.5
29
86
NG2AA
NOMESCO Finland
Patella X-ray examination
28.2
8.5
11
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.7
8.5
48
192
R52.9
ICD-10 Finland
Pain, unspecified
2.9
8.5
42
157
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
91.9
8.4
9
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
91.9
8.4
9
*
P01BA01
ATC
chloroquine; systemic
91.9
8.4
9
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
13.1
8.4
14
11
L04AC07
ATC
tocilizumab; parenteral
+∞
8.4
8
*
L04AA11
ATC
[U] etanercept
+∞
8.4
8
*
L04AA17
ATC
[U] adalimumab
+∞
8.4
8
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
8.4
8
*
J01FA01
ATC
erythromycin; systemic
2.5
8.3
57
251
R03AC02
ATC
salbutamol; inhalant
1.9
8.3
218
1572
C03CA01
ATC
furosemide; systemic
2.0
8.3
111
643
J01DA09
ATC
[U] cefadroxil
2.0
8.2
110
637
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
8.2
144
914
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
8.2
182
1245
WZC30
NOMESCO Finland
Teaching
2.2
8.0
73
364
R01AD08
ATC
fluticasone; nasal
1.9
8.0
121
729
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.9
8.0
24
65
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
8.0
54
236
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
8.0
105
604
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
6.3
7.9
20
33
R03DC03
ATC
montelukast; oral
2.2
7.8
71
354
SPAT1104
SPAT
Monitoring of emergency patient
3.2
7.8
31
102
L12
ICPC
Hand/finger symptom/complaint
2.3
7.8
67
327
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.7
7.7
18
40
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
7.7
37
136
NDL52
NOMESCO Finland
Tenosynovectomy of hand
18.8
7.6
11
6
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
18.8
7.6
11
6
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.3
7.6
14
14
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.5
100
575
R5110, ,
SPAT
3.4
7.5
27
83
NDG30
NOMESCO Finland
Fusion of wrist, total
81.5
7.4
8
*
M23.8
ICD-10 Finland
Other internal derangements of knee
13.7
7.4
12
9
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
7.4
89
494
J01AA02
ATC
doxycycline; systemic
2.0
7.4
310
2545
M10.0
ICD-10 Finland
Idiopathic gout
8.6
7.4
15
18
SPAT1263
SPAT
Sampling
1.8
7.4
162
1095
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
11.2
7.3
13
12
M03BX02
ATC
tizanidine; oral
1.8
7.3
241
1833
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
7.3
7
*
L04AA24
ATC
abatacept; parenteral
+∞
7.3
7
*
3005
Kela drug reimbursment
Tofacitinib
+∞
7.3
7
*
212
Kela drug reimbursment
Gout
+∞
7.3
7
*
291
Kela drug reimbursment
Tofacitinib
+∞
7.3
7
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
+∞
7.3
7
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
6.0
7.3
19
33
J01FA09
ATC
clarithromycin; systemic
1.9
7.3
128
807
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
7.3
51
227
1XC02, ,
NOMESCO Finland
16.1
7.3
11
7
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
16.1
7.3
11
7
HMAK, ,
NOMESCO Finland
2.3
7.2
56
261
M01AH03
ATC
valdecoxib; oral
3.2
7.2
29
96
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
30.6
7.2
9
*
N02BF02
ATC
pregabalin; oral
3.4
7.1
25
76
N02BE01
ATC
paracetamol; systemic, rectal
2.2
7.1
343
2934
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.8
7.1
208
1525
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
10.3
7.1
13
13
M05BA04
ATC
alendronic acid; oral
2.8
7.0
36
137
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
7.0
95
549
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
6.9
24
72
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
6.9
35
132
RF420, ,
NOMESCO Finland
14.1
6.9
11
8
S76
ICPC
Skin infection other
3.3
6.8
26
83
M05BA07
ATC
risedronic acid; oral
5.8
6.8
18
32
N06AA09
ATC
amitriptyline; systemic
2.7
6.8
38
151
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
100
593
R02
ICPC
Shortness of breath/dyspnoea
2.4
6.8
50
227
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
6.8
163
1125
RF410, ,
NOMESCO Finland
17.1
6.8
10
6
SPAT1216
SPAT
Assessment of functional ability
2.2
6.7
62
310
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
23.0
6.7
9
*
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
23.0
6.7
9
*
L13
ICPC
Hip symptom/complaint
2.2
6.7
61
304
Z50.1
ICD-10 Finland
Other physical therapy
3.5
6.7
23
69
R06.0
ICD-10 Finland
Dyspnoea
1.9
6.5
98
585
J01FA10
ATC
azithromycin; systemic
1.7
6.5
221
1672
L03
ICPC
Low back symptom/complaint
1.9
6.5
98
586
SPAT1254
SPAT
Administration of medicine
2.2
6.5
57
280
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.0
6.4
79
440
ND2BG
NOMESCO Finland
MRI of hand
70.9
6.4
7
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
70.9
6.4
7
*
9531
FHL
Arthrodesis of the hand joint
70.9
6.4
7
*
A02BC03
ATC
lansoprazole; oral
1.8
6.4
115
725
N03AX12
ATC
[U] gabapentin; oral
2.2
6.4
56
274
XA402
NOMESCO Finland
ENMG
6.1
6.4
16
27
M02AA07
ATC
piroxicam; topical
1.8
6.3
134
888
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
6.3
44
195
M15.8
ICD-10 Finland
Other polyarthrosis
9.5
6.3
12
13
Z00.0
ICD-10 Finland
General medical examination
2.0
6.3
77
428
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.3
87
505
XX9XE
NOMESCO Finland
Other ultrasound examination
18.4
6.3
9
5
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
18.4
6.3
9
5
ZX120
NOMESCO Finland
Intravenous
2.4
6.3
42
183
293
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
3006
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
6.3
6
*
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.5
6.2
17
32
R21
ICPC
Throat symptom/complaint
2.0
6.2
78
438
-1, ,
NOMESCO Finland
1.8
6.2
126
826
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
6.2
61
314
WZA10
NOMESCO Finland
Extensive medical or dental certificate
8.8
6.1
12
14
M01AX01
ATC
nabumetone; oral
4.0
6.0
17
44
J45.8
ICD-10 Finland
Mixed asthma
4.0
6.0
17
44
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.2
6.0
24
79

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
200
367
9.90
117.91
1.7
1.1
73.29
2.77
u/ml
11.69
109
162
194
390
8.72
103.71
1.7
1.2
78.51
14.87
iu/ml
8.07
123
119
158
313
7.69
83.55
1.5
1.2
517.69
494.55
titre
0.05
52
66
55
20
31.72
82.42
1.9
1.1
13677.47
8941.53
e6/l
0.27
45
15
296
1373
5.45
53.72
10.4
5.6
—
—
—
0
0
303
1457
5.45
51.81
10.6
4.8
0.04
0.04
e9/l
1.68
290
1257
302
1453
5.40
51.47
10.6
4.8
0.59
0.57
e9/l
0.90
289
1247
305
1492
5.40
50.51
10.6
4.8
1.78
1.95
e9/l
1.12
291
1315
287
1371
4.87
48.14
10.9
5.0
3.02
2.90
%
0.39
282
1277
282
1330
4.80
48.12
10.7
4.9
0.77
0.68
%
2.03
274
1233
304
1522
5.16
47.77
10.8
5.1
0.19
0.19
e9/l
0.26
293
1333
288
1387
4.84
47.58
10.6
4.9
57.84
57.12
%
0.56
282
1298
286
1379
4.77
46.94
11.4
5.2
8.64
8.52
%
0.27
281
1286
288
1412
4.71
45.78
11.2
5.0
27.52
27.83
%
0.22
282
1322
320
1749
5.15
42.63
14.5
9.0
3.96
4.05
e9/l
0.37
305
1530
101
239
5.32
41.80
4.9
4.3
0.09
0.11
%
0.07
32
75
47
9
58.93
40.50
1.5
1.1
—
—
—
0
0
101
256
4.94
38.30
5.0
4.2
0.61
0.98
%
0.81
31
92
92
222
5.08
36.92
5.0
4.5
0.00
0.13
%
0.71
22
63
349
2174
5.75
35.85
10.9
3.2
14.63
11.77
mm/h
2.95
344
1980
92
232
4.85
34.90
4.7
4.3
0.46
0.66
%
0.41
26
74
170
684
3.58
33.40
3.3
2.3
336.13
11087.73
umol/l
4.71
159
601
31
28
11.92
29.68
1.4
1.3
—
—
—
0
0
319
2082
3.63
25.32
7.3
3.8
—
—
—
0
0
85
277
3.63
22.15
4.3
4.2
—
—
—
0
0
69
211
3.74
19.64
3.4
2.8
9.96
10.39
g/l
0.36
61
194
35
62
6.09
19.33
1.3
1.2
2.56
16.56
u/ml
—
5
12
34
63
5.81
17.92
1.3
1.2
3.96
3.12
u/ml
—
5
10
206
1208
2.45
17.26
2.6
2.2
80.51
75.41
nmol/l
1.58
193
1084
26
15
18.43
17.16
1.5
1.0
—
—
—
0
0
55
171
3.57
15.14
4.1
2.1
3.87
7.42
e9/l
0.85
44
144
25
44
5.99
13.84
3.2
2.8
3.62
4.26
e9/l
0.80
25
44
226
1489
2.19
13.14
4.8
3.3
0.01
0.01
estimate
0.20
67
283
25
47
5.61
12.94
3.2
3.6
56.04
55.19
%
0.10
25
47
52
190
3.00
10.94
1.3
1.5
—
—
—
0
0
219
1491
2.04
10.93
6.4
4.6
0.00
0.00
estimate
0.50
66
273
20
19
11.01
10.89
1.2
1.2
—
—
—
0
0
215
1462
2.02
10.68
7.3
6.9
1.23
1.21
mmol/l
2.14
187
1249
26
62
4.42
10.25
1.0
1.0
—
—
—
0
0
49
180
2.96
10.20
2.1
1.8
1.15
1.47
g/l
0.74
43
163
217
1501
1.97
10.05
5.0
3.3
0.00
0.02
estimate
0.80
66
258
367
3117
3.15
9.89
24.1
12.3
15.42
25.39
mg/l
12.71
349
2380
75
357
2.35
9.27
1.7
2.0
—
—
—
0
0
140
857
1.97
9.03
1.8
2.1
94.66
356.42
u/l
1.65
131
812
64
293
2.41
8.60
1.3
1.6
—
—
—
0
0
178
1223
1.82
7.78
4.2
3.0
5.50
5.78
ph
—
6
110
138
886
1.85
7.45
4.1
3.4
—
—
—
0
0
77
404
2.12
7.44
1.3
1.6
—
—
—
0
0
192
1366
1.78
7.34
15.8
8.3
0.00
0.00
e9/l
0.84
173
1105
133
848
1.85
7.32
4.5
3.0
—
—
—
0
0
10
5
20.45
7.16
1.9
1.0
—
—
—
0
0
31
109
3.00
6.96
3.5
3.6
0.51
0.30
g/l
—
9
45
126
803
1.83
6.87
5.8
3.4
0.00
0.00
estimate
0.50
65
263
232
1771
1.74
6.71
4.8
4.8
6.45
6.74
mmol/l
1.23
218
1656
18
33
5.66
6.69
2.3
5.5
—
—
—
0
0
34
132
2.72
6.39
4.3
3.6
—
—
—
0
0
146
997
1.73
6.18
2.6
3.9
2.34
2.36
mmol/l
0.77
127
889
187
1368
1.69
6.13
16.0
10.9
1.25
1.21
inr
0.29
76
436
95
578
1.84
5.92
1.7
1.6
2.57
2.40
g/l
0.45
66
362
41
189
2.30
5.41
2.1
2.6
—
—
—
0
0
116
780
1.69
5.03
4.2
4.0
—
—
—
0
0
119
813
1.66
4.84
3.4
3.0
1156.18
1206.21
ng/l
0.06
104
691
13
25
5.34
4.81
1.2
1.1
—
—
—
0
0
167
1245
1.59
4.74
4.9
5.1
34.48
35.58
g/l
1.45
153
1162
174
1312
1.58
4.69
6.4
6.0
1.22
1.21
mmol/l
1.58
161
1200
16
48
3.43
4.65
1.7
4.4
2.78
1.56
%
0.27
16
43
93
603
1.71
4.57
3.1
2.5
3.81
7.77
e6/l
1.85
85
549
15
46
3.35
4.23
1.5
1.4
—
—
—
0
0
140
1025
1.56
4.18
4.2
3.4
194.58
81.39
e6/l
0.31
100
709
36
180
2.10
3.93
2.9
2.9
—
—
—
0
0
52
300
1.84
3.79
1.6
1.5
—
—
—
0
0
165
1285
1.48
3.57
2.4
2.0
—
—
—
0
0
42
231
1.91
3.54
2.2
3.1
64.99
66.75
g/l
0.94
42
211
99
697
1.56
3.43
2.5
1.9
3.30
3.04
mg/l
0.53
89
580
13
37
3.60
3.43
1.6
1.8
—
—
—
0
0
75
497
1.63
3.35
1.3
1.7
—
—
—
0
0
44
251
1.85
3.33
3.6
3.5
1.22
1.23
mmol/l
0.77
39
210
13
43
3.09
3.28
1.3
1.2
—
—
—
0
0
6
7
8.68
3.27
1.2
1.1
244.83
353.34
iu/ml
—
6
7
148
1144
1.47
3.27
1.9
1.9
95.08
95.61
pmol/l
0.04
91
587
8
15
5.42
3.20
1.5
2.2
0.20
0.21
e9/l
—
8
15
52
317
1.74
3.17
2.9
2.8
1.54
1.80
%
2.03
46
284
77
521
1.59
3.15
1.5
1.6
1003.41
1212.77
nmol/l
1.34
65
396
147
1147
1.45
3.05
4.4
3.3
23.34
36.10
ng/l
1.21
111
781
121
914
1.46
2.96
3.1
2.2
—
—
—
0
0
167
1340
1.42
2.95
3.3
2.4
—
—
—
0
0
37
208
1.86
2.94
2.4
4.1
78.42
85.81
ng/l
0.23
32
184
41
239
1.80
2.91
1.7
2.9
63.46
70.87
e9/l
1.05
36
185
325
2951
1.54
2.87
5.3
4.5
1.87
2.34
mu/l
0.58
308
2675
23
110
2.16
2.84
1.3
1.2
—
—
—
0
0
15
59
2.60
2.82
3.1
2.3
—
—
—
0
0
8
214
0.36
2.76
1.1
1.5
—
—
—
0
0
53
339
1.65
2.72
1.4
1.5
—
—
—
0
0
161
1299
1.40
2.70
2.9
2.6
115.46
122.49
ug/l
0.21
156
1212
367
3446
1.79
2.66
25.9
14.5
75.02
75.24
umol/l
0.06
367
3446
19
87
2.24
2.61
1.6
1.4
301.00
291.80
ug/g
—
10
53
90
657
1.48
2.59
1.9
1.5
0.78
1.16
mg/l
1.86
72
501
53
347
1.61
2.49
1.3
1.3
—
—
—
0
0
325
2983
1.48
2.41
5.2
5.3
38.54
39.83
mmol/mol
1.93
305
2753
23
119
1.99
2.35
2.2
1.6
—
—
—
0
0
39
241
1.69
2.29
4.5
7.7
10.27
9.13
mmol/l
0.32
39
227
7
18
3.94
2.26
1.7
2.8
671.00
574.50
e6/l
—
7
18
59
406
1.53
2.25
1.3
1.2
—
—
—
0
0
89
671
1.42
2.15
1.6
1.5
21.48
21.24
nmol/l
0.05
76
561
195
2235
0.75
2.13
3.5
3.5
—
—
—
0
0
191
1634
1.32
2.05
6.9
6.7
9.68
11.34
umol/l
2.10
182
1565
6
15
4.04
2.04
1.0
1.1
—
—
—
0
0
112
886
1.37
2.03
3.5
3.0
13.29
64.86
e6/l
3.11
94
669
240
2125
1.32
2.00
3.7
2.9
47.45
49.96
u/l
0.22
230
1988
11
45
2.49
1.94
1.0
1.3
—
—
—
0
0
100
793
1.35
1.77
3.4
2.9
0.16
0.72
e6/l
3.14
81
585
6
19
3.19
1.66
1.3
1.2
66.00
80.58
umol/l
—
6
19
36
239
1.56
1.64
5.2
3.1
—
—
—
0
0
70
532
1.38
1.62
2.7
3.0
2.46
2.46
mmol/l
0.10
64
468
13
64
2.07
1.56
1.3
1.2
12.33
11.78
u/l
—
6
53
38
261
1.50
1.50
4.5
3.3
—
—
—
0
0
49
355
1.43
1.49
2.3
2.1
139.37
142.99
ug/g
0.04
39
275
350
3329
1.41
1.48
19.6
14.5
3.97
3.96
mmol/l
0.30
343
3226
103
1241
0.77
1.48
3.0
2.8
—
—
—
0
0
349
3319
1.40
1.47
19.3
14.4
139.76
139.72
mmol/l
0.09
341
3218
268
2461
1.27
1.44
4.6
3.8
15.15
14.74
pmol/l
1.75
253
2224
83
660
1.33
1.44
1.6
1.6
452.89
13201160.87
pmol/l
0.50
71
553
9
39
2.34
1.44
3.3
2.7
—
—
—
0
0
9
40
2.28
1.41
1.2
1.3
47.17
62.27
mu/l
—
9
35
84
673
1.31
1.38
5.4
3.2
—
—
—
0
0
84
675
1.31
1.35
1.2
1.3
0.58
2.20
u/ml
1.34
27
174
9
42
2.17
1.34
1.2
1.3
—
—
—
0
0
14
244
0.56
1.34
1.4
1.6
—
—
—
0
0
6
24
2.52
1.31
1.2
2.1
—
—
—
0
0
90
734
1.29
1.30
11.0
6.7
—
—
—
0
0
56
427
1.36
1.29
1.5
1.3
—
—
—
0
0
340
3236
1.34
1.28
4.3
4.2
4.68
4.76
mmol/l
0.67
324
3005
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
374
3624
1.49
1.17
33.2
18.0
40.61
39.98
%
1.91
367
3380
8
39
2.07
1.16
1.3
1.4
—
—
—
0
0
7
30
2.36
1.13
1.9
2.5
—
—
—
0
0
8
41
1.97
1.09
2.0
2.2
—
—
—
0
0
8
41
1.97
1.09
2.0
2.4
32.00
32.02
pg
—
8
41
22
145
1.55
1.08
2.4
2.3
—
—
—
0
0
12
67
1.82
1.05
2.2
2.0
—
—
—
0
0
326
3112
1.26
1.00
4.1
3.8
1.28
1.26
mmol/l
0.16
308
2858
344
3306
1.29
0.99
4.6
4.6
2.75
2.83
mmol/l
0.81
330
3050
12
69
1.76
0.97
3.6
4.5
—
—
—
0
0
108
934
1.21
0.94
3.7
3.7
19.56
9.67
mg/mmol
0.40
75
594
45
351
1.32
0.92
2.0
4.2
3.00
34.62
ug/l
0.93
36
297
335
3218
1.25
0.90
4.4
4.2
1.50
1.50
mmol/l
0.04
319
2968
7
128
0.54
0.89
3.9
6.1
0.74
0.89
%
—
7
122
7
128
0.54
0.89
4.4
6.1
1.11
1.52
%
—
7
121
6
30
2.01
0.87
1.8
1.3
—
—
—
0
0
79
668
1.23
0.86
5.4
3.4
1.02
1.02
kg/l
0.09
23
91
101
877
1.20
0.84
3.2
3.1
84.92
446.56
mg/l
1.37
72
556
30
224
1.37
0.83
1.1
1.1
—
—
—
0
0
331
3186
1.23
0.80
4.5
4.2
5.82
5.92
mmol/l
0.84
312
2914
98
853
1.20
0.80
4.3
4.1
7.40
7.40
ph
0.27
32
165
24
324
0.72
0.78
1.2
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.4
—
1.04
—
0
27
25
334
0.73
0.77
1.3
1.7
—
—
—
0
0
9
53
1.71
0.76
4.7
3.2
—
—
—
0
0
8
132
0.60
0.75
3.4
3.7
26.13
24.00
mmol/l
—
8
127
7
38
1.86
0.74
1.4
1.9
72.29
16.70
ug/l
—
7
38
5
25
2.01
0.73
1.6
1.2
—
—
—
0
0
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
106
939
1.18
0.71
3.1
3.0
6.93
7.39
mmol/l
0.57
100
798
10
157
0.63
0.70
24.2
11.4
—
—
—
0
0
7
41
1.72
0.70
1.4
1.1
—
—
—
0
0
7
41
1.72
0.70
1.9
3.1
—
—
—
0
0
12
77
1.58
0.69
1.5
1.4
36.31
38.53
g/l
0.87
12
67
21
282
0.73
0.68
13.0
9.1
124.33
121.89
g/l
0.19
21
277
21
154
1.38
0.66
3.9
3.3
—
—
—
0
0
13
188
0.68
0.64
4.4
7.2
24.72
24.67
mmol/l
0.02
13
180
88
776
1.17
0.62
3.4
2.8
—
—
—
0
0
5
30
1.67
0.61
1.4
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
1.59
—
0
21
0
23
0.00
0.58
0.0
17.7
—
1684.65
—
0
23
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
35
290
1.23
0.49
1.6
1.5
—
—
—
0
0
34
281
1.23
0.49
1.1
1.4
—
—
—
0
0
15
111
1.37
0.47
1.0
1.0
—
—
—
0
0
5
82
0.60
0.46
1.0
1.4
—
—
—
0
0
7
51
1.38
0.44
1.1
1.0
—
—
—
0
0
17
217
0.77
0.42
3.9
2.6
4.29
4.54
kpa
0.21
17
206
0
15
0.00
0.41
0.0
1.3
—
15.74
—
0
9
8
59
1.36
0.41
3.5
2.0
—
—
—
0
0
21
168
1.26
0.41
1.2
1.3
—
—
—
0
0
5
34
1.48
0.40
1.0
1.3
—
—
—
0
0
7
101
0.69
0.40
4.9
4.2
—
—
—
0
0
94
863
1.12
0.39
4.7
4.5
2.38
3.06
ug/l
0.59
85
775
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
6
44
1.37
0.34
2.7
2.4
—
—
—
0
0
6
44
1.37
0.34
2.7
2.4
3.85
4.02
mmol/l
—
6
44
6
44
1.37
0.34
2.7
2.4
105.00
104.55
mmol/l
—
6
44
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
6
89
0.67
0.33
1.0
1.4
—
—
—
0
0
6
46
1.31
0.33
2.8
1.9
161.67
210.40
pmol/l
—
6
40
6
90
0.66
0.33
1.0
1.4
—
—
—
0
0
6
90
0.66
0.33
1.0
1.4
—
—
—
0
0
6
90
0.66
0.33
1.0
1.4
—
—
—
0
0
16
198
0.80
0.33
4.2
5.1
—
—
—
0
0
76
826
0.90
0.32
1.6
1.7
1.46
1.33
mmol/l
0.70
69
680
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
33
288
1.16
0.30
1.5
1.5
—
—
—
0
0
27
232
1.18
0.29
1.9
2.7
129.50
175.80
ng/l
0.35
22
217
8
64
1.26
0.27
1.1
1.2
—
—
—
0
0
20
235
0.84
0.26
1.3
1.2
54.83
144.24
iu/ml
—
8
89
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
83
882
0.93
0.23
1.5
1.4
—
—
—
0
0
10
124
0.80
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
12
98
1.23
0.21
2.9
8.0
1.52
1.22
mmol/l
0.35
12
87
64
597
1.09
0.21
3.2
2.7
524.19
538.68
mosm/kgh2o
0.24
57
516
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
58.71
—
0
7
0
12
0.00
0.21
0.0
4.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
13
108
1.21
0.20
1.5
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
6.1
—
0.65
—
0
14
9
111
0.81
0.20
8.6
9.3
—
—
—
0
0
9
111
0.81
0.20
1.4
1.3
—
—
—
0
0
59
550
1.09
0.20
3.1
3.7
108.96
502.04
ng/l
1.60
35
418
7
58
1.21
0.18
1.1
1.2
—
—
—
0
0
7
59
1.19
0.18
1.6
2.6
—
—
—
0
0
5
69
0.72
0.17
1.0
1.3
—
—
—
0
0
42
452
0.92
0.16
2.9
2.5
2.67
3.15
e6/l
0.12
22
232
340
3364
1.07
0.16
18.8
11.8
—
—
—
0
0
9
82
1.10
0.15
1.1
1.3
—
—
—
0
0
26
239
1.09
0.12
1.6
1.4
—
—
—
0
0
49
514
0.95
0.10
3.7
2.8
0.79
0.86
ug/l
0.19
40
324
12
134
0.89
0.09
3.3
2.3
0.71
0.65
%
0.22
12
134
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
17
184
0.92
0.07
1.6
1.6
—
—
—
0
0
8
77
1.04
0.07
1.9
3.7
27.75
34.43
umol/l
—
8
67
10
89
1.13
0.07
2.2
2.8
—
—
—
0
0
20
212
0.94
0.05
1.3
1.2
—
—
—
0
0
22
232
0.95
0.05
12.7
9.0
—
—
—
0
0
93
917
1.02
0.03
3.9
2.8
—
—
—
0
0
12
112
1.07
0.03
1.8
2.8
—
—
—
0
0
13
138
0.94
0.02
3.7
2.3
0.98
1.25
%
1.07
13
138
19
197
0.96
0.01
2.0
3.0
34.37
68.10
u/ml
0.73
19
190
26
266
0.98
0.00
4.0
3.5
5.97
5.80
kpa
0.45
26
255
0
5
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
30.89
—
0
9
8
88
0.91
-0.00
3.0
4.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.7
—
26.79
—
0
9
0
8
0.00
-0.00
0.0
1.4
—
68.00
—
0
8
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
87
0.92
-0.00
1.6
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
1.72
—
0
5
0
8
0.00
-0.00
0.0
6.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
74.24
—
0
5
8
89
0.90
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PALINDROMIC and mortality.

Females

Parameter HR [95% CI] p-value
M13_PALINDROMIC 1.065 [0.85, 1.33] 0.575
Birth year 0.998 [0.99, 1.01] 0.617

During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 915 females with M13_PALINDROMIC died.

Males

Parameter HR [95% CI] p-value
M13_PALINDROMIC 1.457 [1.19, 1.78] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 583 males with M13_PALINDROMIC died.

Mortality risk

Mortality risk for people of age

years, who have M13_PALINDROMIC.

N-year risk Females Males
1 0.084% 0.246%
5 0.568% 1.694%
10 1.612% 4.199%
15 3.344% 7.854%
20 5.978% 13.26%

Relationships between endpoints

↥

Index endpoint: M13_PALINDROMIC – Palindromic rheumatism

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data